drugset / Trial / NCT04708210
Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors
NaSingle-groupOpen-labelTreatment
Summary
An open-label, multicenter, phase Ia/Ib study to evaluate the safety, tolerance and preliminary efficacy of IBI319 in patients with advanced malignant tumors
Timeline
- Start
- 2021-04-28
- Primary completion
- 2022-12-21
- Completion
- 2023-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IBI319 | Unknown | — | Intravenous |